Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Vagner

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Analytical Biochemistry|October 27, 2009
Optimization of time-resolved fluorescence assay for detection of europium-tetraazacyclododecyltetraacetic acid-labeled ligand-receptor interactionsChanna R De Silva, Josef Vagner, Ronald Lynch, et al.
Analytical Biochemistry|July 12, 2005
Development of a lanthanide-based assay for detection of receptor-ligand interactions at the delta-opioid receptorHeather L Handl, Josef Vagner, Henry I Yamamura, et al.
Journal of Medicinal Chemistry|February 8, 2011
Potent agonists of the protease activated receptor 2 (PAR2)Scott Boitano, Andrea N Flynn, Stephanie M Schulz, et al.
Bioscience Reports|September 17, 2015
Oestrogen receptors interact with the α-catalytic subunit of AMP-activated protein kinaseYulia Lipovka, Hao Chen, Josef Vagner, et al.
Expert Opinion on Therapeutic Targets|December 9, 2004
Hitting multiple targets with multimeric ligandsHeather L Handl, Josef Vagner, Haiyong Han, et al.
Journal of Medicinal Chemistry|December 13, 2006
Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptorJinfa Ying, Xuyuan Gu, Minying Cai, et al.
The Journal of Pain|June 14, 2023
Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated MiceMoeno Kume, Ayesha Ahmad, Kathryn A DeFea, et al.
International Journal of Peptide Research and Therapeutics|August 29, 2009
Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin ReceptorsJatinder S Josan, Josef Vagner, Heather L Handl, et al.
American Journal of Physiology. Cell Physiology|November 9, 2018
Multivalent activation of GLP-1 and sulfonylurea receptors modulates β-cell second-messenger signaling and insulin secretionNathaniel J Hart, Craig Weber, Klearchos K Papas, et al.
Advances in Experimental Medicine and Biology|April 30, 2009
Synthesis of bivalent MSH ligands and evaluation of their binding to hMC4R using MSH lanthaligandSteve M Fernandes, Rajesh Sankaranarayanan, Liping Xu, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Analytical Biochemistry|October 27, 2009
Optimization of time-resolved fluorescence assay for detection of europium-tetraazacyclododecyltetraacetic acid-labeled ligand-receptor interactionsChanna R De Silva, Josef Vagner, Ronald Lynch, et al.
Analytical Biochemistry|July 12, 2005
Development of a lanthanide-based assay for detection of receptor-ligand interactions at the delta-opioid receptorHeather L Handl, Josef Vagner, Henry I Yamamura, et al.
Journal of Medicinal Chemistry|February 8, 2011
Potent agonists of the protease activated receptor 2 (PAR2)Scott Boitano, Andrea N Flynn, Stephanie M Schulz, et al.
Bioscience Reports|September 17, 2015
Oestrogen receptors interact with the α-catalytic subunit of AMP-activated protein kinaseYulia Lipovka, Hao Chen, Josef Vagner, et al.
Expert Opinion on Therapeutic Targets|December 9, 2004
Hitting multiple targets with multimeric ligandsHeather L Handl, Josef Vagner, Haiyong Han, et al.
Journal of Medicinal Chemistry|December 13, 2006
Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptorJinfa Ying, Xuyuan Gu, Minying Cai, et al.
The Journal of Pain|June 14, 2023
Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated MiceMoeno Kume, Ayesha Ahmad, Kathryn A DeFea, et al.
International Journal of Peptide Research and Therapeutics|August 29, 2009
Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin ReceptorsJatinder S Josan, Josef Vagner, Heather L Handl, et al.
American Journal of Physiology. Cell Physiology|November 9, 2018
Multivalent activation of GLP-1 and sulfonylurea receptors modulates β-cell second-messenger signaling and insulin secretionNathaniel J Hart, Craig Weber, Klearchos K Papas, et al.
Advances in Experimental Medicine and Biology|April 30, 2009
Synthesis of bivalent MSH ligands and evaluation of their binding to hMC4R using MSH lanthaligandSteve M Fernandes, Rajesh Sankaranarayanan, Liping Xu, et al.
Pageof 8